ArticleFrontiers in endocrinology2026
Effects of diabetes mellitus during pregnancy on pregnancy outcomes and growth and development of children aged 0-6 years: a retrospective cohort study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gestational diabetes mellitus (GDM) and pre-gestational diabetes mellitus (PGDM) are jointly termed as diabetes mellitus during pregnancy. This condition exhibits a relatively high incidence rate and exerts adverse impacts on both the mother and the fetus. Objective: To investigate the differential pregnancy outcomes and offspring development between pregnant women with and without diabetes mellitus during pregnancy. Methods: A retrospective cohort study was carried out in China. From 2014 to 2016, all pregnant women in a specific region of Beijing who met the exclusion criteria, along with their offspring who had undergone physical examinations at ages ranging from 0 to 6, were selected as the research subjects between 2014 and 2023. We analyzed the outcomes separately for women with PGDM and GDM. SPSS 27.0 and R 4.2.2 were used to analyze the data. Results: This three-year retrospective study included 49,912 deliveries from a specific region of Beijing, among which 49,765 were live births. The overall prevalence of diabetes during pregnancy was 8.6%, comprising 4,003 cases of GDM and 284 cases of PGDM. PGDM significantly increased the risks of neonatal hypoglycemia ( Conclusions: Diabetes mellitus during pregnancy is associated with a substantially increased risk of adverse outcomes for both the mother and the neonate. Nevertheless, the influence on childhood physical development remains indeterminate. Strengthened screening and management of high-risk pregnant women, particularly those with diabetes, are of critical importance for reducing the incidence of adverse pregnancy outcomes and enhancing the health of both mothers and their progeny.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.